Evidence map›Paper›PMID 38256704›Full record

ArticlePlants (Basel, Switzerland)2024

Furofuranoid-Type Lignans and Related Phenolics from

Mohamed A A Orabi, Reda A Abdelhamid, Hanan Elimam, Yaseen A M M Elshaier, Ahmed A Ali, Nayef Aldabaan, Abdulaziz Hassan Alhasaniah, Mohamed S Refaey

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Plants (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Mohamed A A OrabiDepartment of Pharmacognosy, College of Pharmacy, Najran University, Najran 66454, Saudi Arabia.ORCID 0000-0002-4288-6829
Reda A AbdelhamidDepartment of Pharmacognosy, Faculty of Pharmacy, Al-Azhar University, Assiut-Branch, Assiut 71524, Egypt.ORCID 0000-0002-3402-193X
Hanan ElimamDepartment of Biochemistry, Faculty of Pharmacy, University of Sadat City, Sadat City 32958, Egypt.ORCID 0000-0003-2585-9957
Yaseen A M M ElshaierDepartment of Organic and Medicinal Chemistry, Faculty of Pharmacy, University of Sadat City, Sadat City 32958, Egypt.ORCID 0000-0003-4332-6345
Ahmed A AliDepartment of Pharmacognosy, Faculty of Pharmacy, Assiut University, Assiut 71526, Egypt.
Nayef AldabaanDepartment of Pharmacology, College of Pharmacy, Najran University, Najran 66454, Saudi Arabia.ORCID 0009-0001-3349-9165
Abdulaziz Hassan AlhasaniahDepartment of Clinical Laboratory Sciences, College of Applied Medical Sciences, Najran University, Najran 66454, Saudi Arabia.ORCID 0000-0002-8389-8682
Mohamed S RefaeyDepartment of Pharmacognosy, Faculty of Pharmacy, University of Sadat City, Sadat City 32958, Egypt.ORCID 0000-0003-3879-104X
Najran University · SAUniversity of Sadat City · EGAl-Azhar University · EGAssiut University · EG

Funding

Deanship of Scientific Research at Najran University, Saudi Arabia National Research Priority Funding Program (NU/NRP/MRC/12/1).
6 · The paper itself

Abstract

Lignan phytomolecules demonstrate promising anti-Alzheimer activity by alleviating dementia and preserving nerve cells. The purpose of this work is to characterize the lignans of

Indexed as

Alzheimer’s diseaseAnisacanthus virgularisanticholinesterasefurofuranoid lignansmolecular dockingtelomerase

Identifiers

PMID38256704
PMCPMC10820861
OpenAlexW4390614187

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.